Hansa Biopharma — Major Shareholding Notification 2020

Nov 5, 2020

Issuer Hansa Biopharma AB

Holder

Consonance Capman GP, LLC

Instrument

Instrument	Ordinary shares (Sw.stamaktier) SE0002148817
Before the transaction
Shares	2,262,527
Voting rights	2,262,527
Transaction
Reason for major shareholding notification Sell
Date	03/11/2020
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	2,212,527
Directly held voting rights	0
Indirectly held voting rights	2,212,527
Percentage
Directly held shares	4.82085 %
Directly held voting rights	0 %
Indirectly held voting rights	4.95909 %

Resulting distribution of total holdings

		Percentage of voting rights:	Number of underlying shares:
Shares		4.95909 %	2,212,527
paragraph, line 2	Instruments - FITA Ch. 4, section 2, first
first paragraph, line 3	Instruments - FITA Ch. 4, section 2,
- Physically settled
- Cash settled
Total		4.95909 %	2,212,527
	Chain of controlling companies Voting rights % Voting rights Company
1,527,356 3.42337		Consonance Capital Master Account LP

490,011	1.0983	Consonance Capital Opportunity Master Fund LP
195,160	0.43743	P Consonance Opportunities Ltd.
Group total holdings
Voting rights		2,212,527
	Percentage of voting rights 4.95909

Published

05/11/2020 13:52

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25